Open original FDA record ↗Recall record
- FDA identifier
- Z-2164-2025
- Company in FDA record
- Abiomed, Inc.
- FDA classification date
- Jul 26, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
A potential issue with the Automated Impella Controller (AIC) not detecting an Impella pump when it is connected
Source facts
- Action
- Initially Abiomed posted their recall notification on their website, HeartRecover.com on 06/23/2025. Consignees were also notified on 06/25/2025 via letter. Consignees were advised that devices were not being removed. They were advised to have a back-up Automated Impella Controller (AIC) available in the event of a device failure and were provided work around instruction for console-to-console transfer and case starts. Additionally, consignees were instructed to forward the notification to all pertinent personnel and customers if further distributed and complete and return the business response form provided.
- Initiated
- 2025-06-23
- Root cause
- Device Design
- Distribution
- Worldwide distribution. US Nationwide, Australia, Austria, Belgium, Brunei Darussalam, Canada, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Hong Kong, India, Ireland, Israel, Italy, Japan, Kuwait, Luxembourg, Malaysia, Mexico, Netherlands, Norway, Pakistan, Panama, Poland, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sweden, Switzerland, Taiwan, Thailand, United Arab Emirates, and United Kingdom.
- Recall number
- Z-2164-2025
- Recall status
- Open, Classified
- CDRH record ID
- 214430
- FDA classified
- 2025-07-26
- Recall event number
- 97078